Latest News-GC Corp. Mediaroom_Page

GC Genome to Present the Latest Lung Cancer Diagnostic Tool at ESMO 2023

- An innovative study of methylation markers and deep learning model enables precise lung cancer di...

2023-10-20 13:10 1292

GC Biopharma Shares its Successful HR System Transformation at SAP Success Connect 2023

YONGIN, South Korea, Oct. 10, 2023 /PRNewswire/ -- GC Biopharma Corp. announced today that it has p...

2023-10-11 08:49 1625

GC Biopharma Signs Power Purchase Agreement with SK E&S

YONGIN, South Korea, Oct. 10, 2023 /PRNewswire/ -- GC Biopharma Corp. announced on today that it ha...

2023-10-10 14:20 1468

FDA Grants Orphan Drug Designation to GC Biopharma's Drug Candidate for Thrombotic Thrombocytopenic Purpura

YONGIN, South Korea, Oct. 5, 2023 /PRNewswire/ -- GC Biopharma Corp. announced today that GC1126A, ...

2023-10-06 08:12 2424

GCCL to be the first in the industry sector to adopt Lab Information Management System (LIMS)

* The first clinical trial sample analysis provider to adopt LIMS * To provide enhanced quality ...

2023-09-05 09:57 1343

GC Biopharma to organize "Donate Blood with Love", a healthy way of giving back to the community

With the participation of all affiliated group entities YONGIN, South Korea, Aug. 30, 2023 /PRNewsw...

2023-08-30 16:05 1380

GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

YONGIN, South Korea, Aug. 25, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biophar...

2023-08-25 15:14 1622

Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements.

* Analyzed the FDA FAERS data…to compare the thrombotic AEs of Hemlibra vs. FVIII replacements. Y...

2023-08-18 08:58 2279

U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid)

YONGIN, South Korea, July 31, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a global biopharmaceut...

2023-07-31 13:20 1680

GC Genome enables the prognosis prediction and targeted treatment in breast cancer patients

YONGIN, South Korea, July 26, 2023 /PRNewswire/ -- GC Genome Corporation, a leading genomic diagnos...

2023-07-27 08:53 1212

GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent

* Striving to further expand its territory to Africa and the Middle East from Southeast Asia and ...

2023-07-21 16:47 2011

GC Genome's New Study Reveals Link Between Gut Microbiome and High Blood Pressure

- A large Korean population study provides scientific evidence that altering the gut microbiome com...

2023-06-15 08:32 1659

GC Biopharma receives a business license for the construction of a plasma fractionation plant and technology transfer in Indonesia

* In recognition of securing high-caliber technology in manufacturing plasma derivatives and a tr...

2023-06-02 08:35 2294

GC Genome to Present the Brand New Liquid Biopsy Platform for Cancer Detection at AACR Annual Meeting 2023

YONGIN, South Korea, April 18, 2023 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics co...

2023-04-18 13:36 1570

GC Biopharma celebrates 'World Hemophilia Day'

* To display a large media façade on its Yong-in R&D Center YONGIN, South Korea, April 17, 2023 /...

2023-04-18 09:03 1652

GC Genome-KAIST team Announces Publication of a Groundbreaking AI-Based Liquid Biopsy Technology for Multi-Cancer Early Detection and Localization in Nature Communications

YONGIN, South Korea, April 11, 2023 /PRNewswire/ -- GC Genome Corporation, a leading genomic diagno...

2023-04-12 11:06 1742

GC Genome Announces Publication Demonstrating Feasibility of Liquid Biopsy Technology to Predict Radiation Therapy Response in Solid Tumors

YONGIN, South Korea, April 9, 2023 /PRNewswire/ -- GC Genome Corporation, a leading genomic diagnos...

2023-04-10 11:39 1595

Latest News